These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

669 related items for PubMed ID: 16634029

  • 21. Increased prevalence of and gene transcription by Chlamydia pneumoniae in cerebrospinal fluid of patients with relapsing-remitting multiple sclerosis.
    Dong-Si T, Weber J, Liu YB, Buhmann C, Bauer H, Bendl C, Schnitzler P, Grond-Ginsbach C, Grau AJ.
    J Neurol; 2004 May; 251(5):542-7. PubMed ID: 15164186
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Natalizumab therapy decreases surface expression of both VLA-heterodimer subunits on peripheral blood mononuclear cells.
    Harrer A, Wipfler P, Einhaeupl M, Pilz G, Oppermann K, Hitzl W, Afazel S, Haschke-Becher E, Strasser P, Trinka E, Kraus J.
    J Neuroimmunol; 2011 May; 234(1-2):148-54. PubMed ID: 21450349
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Natalizumab exerts a suppressive effect on surrogates of B cell function in blood and CSF.
    Warnke C, Stettner M, Lehmensiek V, Dehmel T, Mausberg AK, von Geldern G, Gold R, Kümpfel T, Hohlfeld R, Mäurer M, Stangel M, Straeten V, Limmroth V, Weber T, Kleinschnitz C, Wattjes MP, Svenningsson A, Olsson T, Hartung HP, Hermsen D, Tumani H, Adams O, Kieseier BC.
    Mult Scler; 2015 Jul; 21(8):1036-44. PubMed ID: 25392339
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. High interindividual variability in the CD4/CD8 T cell ratio and natalizumab concentration levels in the cerebrospinal fluid of patients with multiple sclerosis.
    Harrer A, Pilz G, Wipfler P, Oppermann K, Sellner J, Hitzl W, Haschke-Becher E, Afazel S, Rispens T, van der Kleij D, Trinka E, Kraus J.
    Clin Exp Immunol; 2015 Jun; 180(3):383-92. PubMed ID: 25603898
    [Abstract] [Full Text] [Related]

  • 29. Reactivation of JC virus and development of PML in patients with multiple sclerosis.
    Khalili K, White MK, Lublin F, Ferrante P, Berger JR.
    Neurology; 2007 Mar 27; 68(13):985-90. PubMed ID: 17389301
    [Abstract] [Full Text] [Related]

  • 30. Rituximab levels in cerebrospinal fluid of patients with neurological autoimmune disorders.
    Petereit HF, Rubbert-Roth A.
    Mult Scler; 2009 Feb 27; 15(2):189-92. PubMed ID: 18971221
    [Abstract] [Full Text] [Related]

  • 31. The distribution of interleukin-2 receptor bearing lymphocytes in multiple sclerosis: evidence for a key role of activated lymphocytes.
    Bellamy AS, Calder VL, Feldmann M, Davison AN.
    Clin Exp Immunol; 1985 Aug 27; 61(2):248-56. PubMed ID: 3930109
    [Abstract] [Full Text] [Related]

  • 32. Natalizumab alters transcriptional expression profiles of blood cell subpopulations of multiple sclerosis patients.
    Lindberg RL, Achtnichts L, Hoffmann F, Kuhle J, Kappos L.
    J Neuroimmunol; 2008 Feb 27; 194(1-2):153-64. PubMed ID: 18178259
    [Abstract] [Full Text] [Related]

  • 33. Natalizumab treatment perturbs memory- and marginal zone-like B-cell homing in secondary lymphoid organs in multiple sclerosis.
    Planas R, Jelčić I, Schippling S, Martin R, Sospedra M.
    Eur J Immunol; 2012 Mar 27; 42(3):790-8. PubMed ID: 22144343
    [Abstract] [Full Text] [Related]

  • 34. [Expression of interleukin 2 receptor and class II histocompatibility antigens on lymphocytes of the cerebrospinal fluid in patients with multiple sclerosis and other neurological diseases].
    Tournier-Lasserve E, Lyon-Caen O, Roullet E, Bach MA.
    Pathol Biol (Paris); 1987 Mar 27; 35(3):303-6. PubMed ID: 3108835
    [Abstract] [Full Text] [Related]

  • 35. JC virus reactivation during prolonged natalizumab monotherapy for multiple sclerosis.
    Chalkias S, Dang X, Bord E, Stein MC, Kinkel RP, Sloane JA, Donnelly M, Ionete C, Houtchens MK, Buckle GJ, Batson S, Koralnik IJ.
    Ann Neurol; 2014 Jun 27; 75(6):925-34. PubMed ID: 24687904
    [Abstract] [Full Text] [Related]

  • 36. Increased prevalence of varicella zoster virus DNA in cerebrospinal fluid from patients with multiple sclerosis.
    Mancuso R, Delbue S, Borghi E, Pagani E, Calvo MG, Caputo D, Granieri E, Ferrante P.
    J Med Virol; 2007 Feb 27; 79(2):192-9. PubMed ID: 17177306
    [Abstract] [Full Text] [Related]

  • 37. Cellular immunoregulatory mechanisms in the central nervous system: characterization of noninflammatory and inflammatory cerebrospinal fluid lymphocytes.
    Matsui M, Mori KJ, Saida T.
    Ann Neurol; 1990 Jun 27; 27(6):647-51. PubMed ID: 2360801
    [Abstract] [Full Text] [Related]

  • 38. In vivo labeling of blood T cells: rapid traffic into cerebrospinal fluid in multiple sclerosis.
    Hafler DA, Weiner HL.
    Ann Neurol; 1987 Jul 27; 22(1):89-93. PubMed ID: 3498435
    [Abstract] [Full Text] [Related]

  • 39. Specific central nervous system recruitment of HLA-G(+) regulatory T cells in multiple sclerosis.
    Huang YH, Zozulya AL, Weidenfeller C, Metz I, Buck D, Toyka KV, Brück W, Wiendl H.
    Ann Neurol; 2009 Aug 27; 66(2):171-83. PubMed ID: 19705413
    [Abstract] [Full Text] [Related]

  • 40. Natalizumab and immune cells.
    McFarland HF, Jacobson S.
    Arch Neurol; 2006 Oct 27; 63(10):1366-7. PubMed ID: 17030649
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 34.